在2011年至2021年期间,韩国的药物诱导死亡统计数据
1Statistics Research Institute, Statistics Korea, Daejeon, Korea.
Ewha medical journal
|July 24, 2025
概括
在韩国,从2011年到2021年,药物诱导的死亡人数显著增加了172.7%,主要是由于年轻人群中的故意自我伤害. 有针对性的政策对于管理这种公共卫生问题至关重要.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 毒理学 毒理学 毒理学
背景情况:
- 药物诱导的死亡率在全球范围内构成了越来越大的公共卫生挑战.
- 了解药物诱导死亡的国家趋势对于有效干预至关重要.
研究的目的:
- 分析2011年至2021年韩国药物诱导死亡统计数据的趋势.
- 确定与药物诱导死亡率相关的人口结构模式和原因.
主要方法:
- 利用韩国统计局的死亡原因统计数据.
- 数据使用韩国疾病和死亡原因标准分类和ICD-10进行分类.
主要成果:
- 药物诱导的死亡人数增加了172.7% (2011年的205人,到2021年的559人).
- 年轻成年人 (25-34岁的男性,35-44岁的女性) 的死亡率显著增加.
- 故意自伤占死亡人数的75%;医疗麻醉剂死亡人数增加了5.5倍.
结论:
- 尽管韩国的死亡率低于美国,但韩国面临着药物诱导死亡的上升趋势.
- 死亡集中在年轻人群中,通常涉及故意自伤.
- 迫切需要系统的管理和有针对性的政策.
相关概念视频
Drug Regulation
1.8K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.8K
Overview of Cell Death
7.8K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.8K
Pharmacovigilance
996
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
996
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
299
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
299
Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
Kinetics of Drug Elimination
3.6K
Eliminating drugs from the body is a vital process that occurs through excretion or metabolism. Understanding the kinetics of drug elimination is crucial for drug development, dosage determination, and optimizing patient outcomes.
Drug clearance depends on the rate of drug elimination and its plasma concentration. Another important parameter is the half-life of a drug, which is the time required for its concentration to decrease by half. In most cases, drug clearance follows first-order...
Drug clearance depends on the rate of drug elimination and its plasma concentration. Another important parameter is the half-life of a drug, which is the time required for its concentration to decrease by half. In most cases, drug clearance follows first-order...
3.6K


